Market Closed -
OTC Markets
01:28:57 15/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.2008
USD
|
+1.49%
|
|
+11.87%
|
+177.73%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
8.742
|
6.821
|
30.61
|
29.03
|
16.05
|
27.78
|
Enterprise Value (EV)
1 |
8.791
|
7.587
|
30.05
|
27.43
|
14.34
|
26.19
|
P/E ratio
|
-0.42
x
|
-4.03
x
|
-24.6
x
|
-10.9
x
|
-6.32
x
|
-9.21
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
71,79,78,421
x
|
4,37,34,62,286
x
|
1,95,02,13,005
x
|
43,96,07,332
x
|
1,42,46,16,000
x
|
EV / Revenue
|
-
|
79,86,10,526
x
|
4,29,35,64,286
x
|
1,84,23,25,385
x
|
39,28,64,544
x
|
1,34,29,60,256
x
|
EV / EBITDA
|
-3.53
x
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-2.67
x
|
-21.1
x
|
-41.5
x
|
-78.3
x
|
-52.6
x
|
-80.9
x
|
FCF Yield
|
-37.4%
|
-4.75%
|
-2.41%
|
-1.28%
|
-1.9%
|
-1.24%
|
Price to Book
|
-0.8
x
|
-0.58
x
|
-3.17
x
|
-3.57
x
|
-2.02
x
|
-3.39
x
|
Nbr of stocks (in thousands)
|
1,51,774
|
1,84,346
|
2,90,182
|
3,42,368
|
3,61,379
|
3,84,233
|
Reference price
2 |
0.0576
|
0.0370
|
0.1055
|
0.0848
|
0.0444
|
0.0723
|
Announcement Date
|
25/03/19
|
28/04/20
|
24/03/21
|
07/03/22
|
01/03/23
|
18/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
0.0095
|
0.007
|
0.0149
|
0.0365
|
0.0195
|
EBITDA
1 |
-2.488
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-2.49
|
-1.33
|
-0.6725
|
-2.502
|
-2.518
|
-2.793
|
Operating Margin
|
-
|
-13,999.78%
|
-9,607.44%
|
-16,805.25%
|
-6,898.13%
|
-14,323.83%
|
Earnings before Tax (EBT)
1 |
-7.703
|
-1.61
|
-0.957
|
-2.528
|
-2.47
|
-2.895
|
Net income
1 |
-7.703
|
-1.61
|
-0.957
|
-2.528
|
-2.47
|
-2.895
|
Net margin
|
-
|
-16,948.39%
|
-13,671.31%
|
-16,979.69%
|
-6,767.75%
|
-14,844.89%
|
EPS
2 |
-0.1388
|
-0.009190
|
-0.004295
|
-0.007757
|
-0.007028
|
-0.007849
|
Free Cash Flow
1 |
-3.287
|
-0.3601
|
-0.7245
|
-0.3502
|
-0.2727
|
-0.3236
|
FCF margin
|
-
|
-3,790.56%
|
-10,350.53%
|
-2,352.65%
|
-747.23%
|
-1,659.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/03/19
|
28/04/20
|
24/03/21
|
07/03/22
|
01/03/23
|
18/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.05
|
0.77
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
0.56
|
1.61
|
1.71
|
1.59
|
Leverage (Debt/EBITDA)
|
-0.0194
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-3.29
|
-0.36
|
-0.72
|
-0.35
|
-0.27
|
-0.32
|
ROE (net income / shareholders' equity)
|
296%
|
133%
|
132%
|
-337%
|
-158%
|
-191%
|
ROA (Net income/ Total Assets)
|
-9,670%
|
-2,754%
|
-85.7%
|
-122%
|
-93.2%
|
-104%
|
Assets
1 |
0.0797
|
0.0585
|
1.117
|
2.079
|
2.651
|
2.78
|
Book Value Per Share
2 |
-0.0700
|
-0.0600
|
-0.0300
|
-0.0200
|
-0.0200
|
-0.0200
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/03/19
|
28/04/20
|
24/03/21
|
07/03/22
|
01/03/23
|
18/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +177.73% | 7.83Cr | | -0.97% | 1.54TCr | | -36.20% | 292.37Cr | | -12.03% | 248.24Cr | | -12.41% | 145.42Cr | | -.--% | 112.5Cr | | +65.31% | 61Cr | | +89.23% | 50Cr | | +16.06% | 25Cr | | -2.35% | 22Cr |
Medical Imaging Systems
|